header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

O3366 CHARNLEY-KERBOULL TOTAL HIP ARTHROPLASTY FOR AVASCULAR NECROSIS OF THE FEMORAL HEAD. A MINIMUM 10-YEAR FOLLOW-UP STUDY



Abstract

Aims: The purpose of this retrospective study was to report on the minimum 10-year follow-up results of a consecutive series of cemented low friction total hip arthroplasties performed for avascular necrosis of the femoral head. Methods: One hundred and twenty-two THAs in 96 patients were performed between January 1980 and December 1990. All prostheses were of Charnley- Kerboull design, combining a 22.2-mm femoral head and an all-polyethylene socket. Both components were cemented. The mean age of the series was 50.8 ± 13.3 years (21–85 years). Eighty hips were graded Ficat III and 42 hips were graded Ficat IV. Results: At the minimum 10-year follow-up evaluation, 59 patients (75 hips) were still alive and had not been revised at a mean of 13.9 years (10–21 years), 7 patients (7 hips) had been revised, 20 patients (24 hips) had died from unrelated causes, and 10 patients (16 hips) were lost to follow-up. The mean dñAubignŽ hip score was 17 ± 1 at the latest follow-up. The mean wear rate for unrevised hips was 0.07± 0.06 mm per year. Revision was performed for polyethylene wear associated with periprosthetic osteolysis in 6 hips and for deep sepsis in one. Three hips had recurrent dislocations. The survival rate at 15 years, using revision for any reason as the end-point, was 88.5% (95% conþdence interval, 80.2 to 96.9%). Conclusions: This series indicated that Charnley Kerboull low friction total hip arthroplasty for avascular necrosis could provide satisfactory long-term clinical and radiologic results.

Theses abstracts were prepared by Professor Dr. Frantz Langlais. Correspondence should be addressed to him at EFORT Central Office, Freihofstrasse 22, CH-8700 Küsnacht, Switzerland.